4//SEC Filing
Goldan Keith A. 4
Accession 0001562180-24-001222
CIK 0001395937other
Filed
Feb 8, 7:00 PM ET
Accepted
Feb 9, 4:05 PM ET
Size
13.1 KB
Accession
0001562180-24-001222
Insider Transaction Report
Form 4
Goldan Keith A.
Chief Financial Officer
Transactions
- Other
Common Stock
2024-01-31$17.42/sh+1,183$20,608→ 4,673 total - Award
Stock Options (Right to buy)
2024-02-07$22.28/sh+70,000$1,559,600→ 70,000 totalExercise: $22.28Exp: 2034-02-07→ Common Stock (70,000 underlying) - Other
Common Stock
2023-07-31$18.12/sh+862$15,619→ 3,490 total - Award
Common Stock
2024-02-07+35,000→ 39,673 total - Award
Common Stock
2024-02-07+11,700→ 51,373 total
Footnotes (5)
- [F1]The Reporting Person is voluntarily filing this Form 4 to report the acquisition of 862 shares by the Reporting Person on 07/31/2023 pursuant to the Issuer's Employee Stock Purchase Plan.
- [F2]The Reporting Person is voluntarily filing this Form 4 to report the acquisition of 1,183 shares by the Reporting Person on 01/31/2024 pursuant to the Issuer's Employee Stock Purchase Plan.
- [F3]Award of restricted stock units ("RSUs"), representing the right to receive one share of Common Stock for each RSU. One third (1/3rd) of the shares of Common Stock subject to such RSU shall vest annually on the anniversary of the Vesting Commencement Date, during the Reporting Person's continued service as an employee, consultant, director or officer of the Company over the three (3) years following the date of grant, until all of the shares subject to such RSU are fully vested.
- [F4]Award of RSUs, representing the right to receive one share of Common Stock for each RSU. The number of shares of Common Stock acquired upon vesting of the RSUs is contingent upon the achievement of pre-established performance metrics, as approved by the Company's Compensation Committee, subject to the Reporting Person's continued service as an employee, consultant, director or officer of the Company.
- [F5]1/48th of the shares subject to the option shall vest monthly over a four-year period.
Documents
Issuer
Syndax Pharmaceuticals Inc
CIK 0001395937
Entity typeother
Related Parties
1- filerCIK 0001495411
Filing Metadata
- Form type
- 4
- Filed
- Feb 8, 7:00 PM ET
- Accepted
- Feb 9, 4:05 PM ET
- Size
- 13.1 KB